ACT | Adoptive T cell therapy |
APC | Antigen presenting cells |
APL | Altered peptide ligand |
HLA | Human leucocyte antigen |
CDR | Complementary-determining region |
NSPM | Nonsynonymous point mutations |
MHC | Major histocompatibility complex |
MS PBMCs |
Mass spectrometry peripheral blood mononuclear cells |
pMHC | Peptide-major histocompatibility complex |
TAA | Tumor-associated antigen |
TCR | T cell receptor |
TILs | Tumor infiltrating lymphocytes |
WES | Whole exome sequencing |